Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-01 Kelsey Stephen Michael See Remarks Grant or award +36,600 296,345
2025-03-01 Kelsey Stephen Michael See Remarks Grant or award · Stock Option (Right to Buy) +128,100 128,100
2025-03-01 Horn Margaret A Chief Operating Officer Grant or award +28,600 156,591
2025-03-01 Horn Margaret A Chief Operating Officer Grant or award · Stock Option (Right to Buy) +100,100 100,100
2025-03-01 Wei Lin Chief Medical Officer Grant or award −20,800 91,651
2025-03-01 Wei Lin Chief Medical Officer Grant or award · Stock Option (Right to Buy) +72,800 72,800
2025-03-01 Wang Xiaolin See Remarks Grant or award +19,000 105,039
2025-03-01 Wang Xiaolin See Remarks Grant or award · Stock Option (Right to Buy) +66,500 66,500
2025-03-01 GOLDSMITH MARK A See Remarks Grant or award +97,400 453,302
2025-03-01 GOLDSMITH MARK A See Remarks Grant or award · Stock Option (Right to Buy) +341,100 0
2025-01-21 Cislini Jeff General Counsel Sale 10b5-1 −2,406 $40.50 $97K 39,222
2024-12-18 GOLDSMITH MARK A See Remarks Option exercise +30,846 $0.49 $15K 355,902
2024-12-18 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) −30,846 0
2024-12-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,329 $45.40 $197K 127,991
2024-12-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −11,714 $45.40 $532K 325,056
2024-12-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −4,663 $45.40 $212K 259,745
2024-12-16 Cislini Jeff General Counsel Sale 10b5-1 −1,599 $45.40 $73K 41,628
2024-12-16 Anders Jack Chief Financial Officer Sale 10b5-1 −2,635 $45.40 $120K 96,470
2024-12-05 Schroeder Thilo Director Purchase +543,478 $46.00 $25.0M 2,096,612
2024-12-05 Schroeder Thilo Director Purchase +760,869 $46.00 $35.0M 760,869

Page 19 of 29 · 569 trades